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ABSTRACT 
 
In several species, adult metabolic phenotype is influenced by the intrauterine environment, 
often in a sex-linked manner.  In horses, there is also a window of susceptibility to 
programming immediately after birth but whether adult glucose-insulin dynamics are altered 
by neonatal conditions remains unknown. Thus, this study investigated the effects of birth 
weight, sex and neonatal glucocorticoid overexposure on glucose-insulin dynamics of young 
adult horses. For the first 5 days after birth, term foals were treated with saline as a control or 
ACTH to raise cortisol levels to those of stressed neonates. At 1 and 2 years of age, insulin 
secretion and sensitivity were measured by exogenous glucose administration and 
hyperinsulinaemic-euglycamic clamp, respectively.  Glucose-stimulated insulin secretion was 
less in males than females at both ages, although there were no sex-linked differences in 
glucose tolerance. Insulin sensitivity was greater in females than males at 1 but not 2 years of 
age.  Birthweight was inversely related to the area under the glucose curve and positively 
correlated to insulin sensitivity at 2 but not 1 years of age.  In contrast, neonatal 
glucocorticoid overexposure induced by ACTH treatment had no effect on whole body 
glucose tolerance, insulin secretion or insulin sensitivity at either age, although this treatment 
altered insulin receptor abundance in specific skeletal muscles of the 2 year old horses.   
These findings show that glucose-insulin dynamics in young adult horses are sexually 
dimorphic and determined by a combination of genetic and environmental factors acting 
during early life.   
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INTRODUCTION 
 
In adult animals including horses, glucose tolerance and insulin sensitivity are influenced by 
the nutritional, metabolic and endocrine conditions existing at the time of study.1-4 There is 
also increasing evidence from a range of species that conditions during intrauterine 
development can affect glucose-insulin dynamics of the adult offspring.5-7 Low birthweight, 
in particular, has been associated with glucose intolerance and insulin insensitivity in adult 
mice, rats, guinea pigs, pigs and sheep as well as in human populations of different ethnicity. 
8-14 Indeed, inducing intrauterine growth restriction experimentally by maternal 
undernutrition, glucocorticoid administration, placental insufficiency or restriction of uterine 
blood flow causes abnormalities in glucose metabolism and insulin action in the offspring 
later in postnatal life.5,6,15,16 In horses, maternal undernutrition and variations in dietary 
composition during pregnancy affect insulin secretion and glucose dynamics of newborn and 
older pre-weaning foals, even when there is no change in birth weight.17-19 Similarly, 
dexamethasone treatment of mares during late pregnancy alters arginine-stimulated insulin 
secretion in their foals 12 weeks after birth relative to controls of the same birth weight.20   
Collectively, the experimental and epidemiological studies have led to the concept that 
postnatal metabolic phenotype can be programmed in utero, particularly by environmental 
conditions suboptimal for normal fetal development.  
 
Recent studies in horses have suggested that there is also a window of susceptibility to 
metabolic and endocrine programming in the early neonatal period.15,16 In contrast to other 
precocious species, the horse matures late in gestation and is born with several of its key 
tissues still not terminally differentiated.16 Indeed, glucocorticoid overexposure of the foal in 
the days immediately after birth alters its subsequent endocrine and metabolic profile.21,22  
For instance, there are changes in insulin secretion in response to both glucose and arginine in 
the foal up to 12-14 weeks after the period of glucocorticoid overexposure.21 In addition, in 2 
week old foals, pancreatic β cell sensitivity to glucose differs with sex with greater insulin 
secretion in females than males.23 However, whether the differences in glucose-insulin 
dynamics seen with sex and neonatal glucocorticoid exposure in pre-weaning foals persist 
into later life remains unknown. This study, therefore, examined glucose tolerance, insulin 
secretion and insulin sensitivity of young adult horses with respect to sex, birth weight and 
neonatal glucocorticoid overexposure.  
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MATERIALS AND METHODS 
Animals  
Nineteen ponies were used in the study. They were born spontaneously at full term (approx. 
330 days of gestation) and were treated intramuscularly with equine tetanus antitoxin shortly 
after birth (1000 IU; Tetanus Antitoxin Intervet Ltd, UK). They were housed with their 
mothers in individual stables for 7 days after birth and then at grazing during the day until 
they were weaned at 5-6 months. Thereafter, until catheterization, they were kept at grazing 
during the day and housed in covered yards at night with access to hay and water.  Body 
condition score was maintained at moderate from weaning until the end of the protocol.24,25 
Colts and fillies occupied separate paddocks and yards from 9 months of age. All animals 
were wormed and had their hooves trimmed regularly. They were also weighed regularly to 
calculate fractional growth rates (g/kg birth weight/week) up to the experiments at 1 and 2 
years of age. 
 
 
Experimental Procedures 
 
All procedures were carried out under the Animal (Scientific Procedures) Act 1986 of the UK 
Government after ethical permission from the University of Cambridge.  
 
Foals  
Foals were injected intramuscularly with either long-acting ACTH1-24 (0.125 mg,  n=9, 4 
males and 5 females, Depot Synacthen, Alliance Pharmaceuticals Ltd, Wiltshire, UK) or 
saline (0.9% NaCl, n= 10, 4 males and 6 females) twice daily at between 08.00 and 09.00h 
and between 16.30h and 17.00h for 5 days after birth beginning on the first day of postnatal 
life. Blood samples were taken daily from the jugular vein immediately before the first daily 
injection from day 1 to day 6 to measure plasma cortisol concentrations. The ACTH dose was 
designed to increase endogenous cortisol concentrations to the levels seen in premature or ill 
newborn foals26,27 and resulted in plasma cortisol concentrations that were higher in ACTH 
than saline treated foals over the 5 days of treatment (Saline, 20.4 ± 1.8 ng/ml, n = 10; 
ACTH, 207.2 ± 49.3 ng/ml, n = 9, P=0.01).21  Foals were assigned to either ACTH or saline 
treatment alternately in the order in which they were born on the basis of their sex to ensure 
an even sex distribution between the two treatment groups.  
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Adults 
Surgical procedures: At 10-13 months (yearling or 1 year old group) and again between 23-
34 months (2 year old group), the ACTH and saline treated ponies were fasted over night 
before catheterisation under general anaesthesia with positive pressure ventilation using strict 
aseptic procedures as described in detail previously.28,29  At both ages, catheters were inserted 
into the caudal vena cava and dorsal aorta via the circumflex artery and vein.28  The catheters 
were filled with heparinised saline (100 IU heparin/ml in 0.9% w/v NaCl), exteriorized via a 
stab wound in the flank and housed in a bag sutured to the side of the horse. At the end of 
surgery, a long stay 16-gauge catheter was placed in a jugular vein (Milacath®, Mila 
International Inc., Erlanger, KY, USA) and the horse was given antibiotics (1 ml/25kg i.m, 
procaine penicillin BP 200 mg and dihydrostreptomycin sulphate BP (vet) 250 mg; Pencillin 
& Strep; Norbrook Laboratories Ltd, UK) and an anti-inflammatory (1.1 mg/kg, flunixin 
meglumine; Finadyne 50mg, Shering-Plough Ltd, Welwyn Garden City, UK) 
intramuscularly. Postoperatively, the horses were housed in individual pens in sight of other 
horses with access to hay and water ad libitum. Catheters were flushed daily with heparinised 
saline (100 IU heparin/ml in 0.9% w/v NaCl) until the onset of physiological assessments. At 
the end of the experimental period as yearlings, the catheters were removed under sedation 
(Xylazine: 1.1 mg/kg i.v Rompun, Bayer Ltd, UK) and the ponies re-catheterised on the 
contralateral side at 2 years of age.  
 
Glucose tolerance tests: Insulin secretion was assessed using a glucose tolerance test. At least 
5-7 days after surgery following an overnight fast, glucose was infused intravenously over 5 
min (0.25g/kg, 40% dextrose; Arnolds, Harlescott, Shrewsbury, UK) via the venous catheter 
and arterial blood samples (5ml) were collected at -30, -15, and 0 min (immediately before) 
and 5, 15, 30, 45, 60, 90, and 120 min after glucose administration. The blood samples were 
placed into tubes containing heparin or EDTA and centrifuged immediately at 4 ºC before 
storage of the plasma at -20ºC until measurement of plasma glucose and insulin 
concentrations.  
 
Insulin sensitivity tests: Between 7-10 days after the glucose tolerance test, insulin sensitivity 
was assessed using a hyperinsulinaemic-euglycaemic clamp (HEC) following an overnight 
fast. After collecting basal blood samples (5ml) from the arterial catheter at 10 min intervals 
for 40-60 min, insulin was infused continuously via the caudal vena cava catheter at a rate of 
5mU/kg/min (Insuvet® Neural, Shoering-Plough Animal Health, Welwyn Garden City, UK 
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in Year 1 or Actrapid Actrapid® HM, Insulin Human biosynthetic 100 IU/ml, Novo Nordisk 
Pharma, Denmark in Year 2) using a peristaltic pump. After insulin infusion for 10 min, 
glucose (40% dextrose, Arnolds, Harlescott, Shrewsbury, Shropshire, UK) was infused at a 
variable rate using a precision infusion pump to maintain glucose levels at basal values. Once 
steady state was established after about 2-5h of insulin and glucose infusion, a second series 
of arterial blood samples (5ml) were collected at 10 min intervals for 40 min for the 
measurement of the concentrations of blood glucose and plasma insulin. After the clamped 
period, the insulin and glucose infusion was stopped and the horses were fed with 500g 
concentrates (Horse Stud Mix; Moulton’s Feed Supplies, Lincolnshire, UK) plus hay ad 
libitum. 
 
At the end of the experimental studies as 2 year olds, the catheters were removed under 
sedation as at 1 year and the animals were either rehomed (n=10) after discharge from the 
Animal (Scientific Procedures) Act 1986 or euthanized (n=9) by intravenous administration 
of a lethal dose of anaesthetic (pentobarbitone sodium; 200 mg/kg, Pentoject, Animal Care 
Ltd, Commond Road, Dunnington, York, UK). For the current study, samples of liver and 
skeletal muscles (biceps, soleus, gastrocnemius and semitendinosus) were collected into 
liquid nitrogen and stored at -80ºC until required for analyses. These and other tissues were 
also collected for teaching and other research studies.  
 
 
Biochemical analyses 
 
Metabolite and hormone concentrations: 
 Blood and plasma glucose concentrations were measured using an automated analyzer 
(Yellow Springs 2300 Stat Plus Glucose/Lactate Analyzer; YSI Ltd., Farnborough, UK).  
Plasma insulin concentrations during the glucose tolerance test and the basal samples from 
the hyperinsulinaemic-euglycaemic clamp were measured using a commercially available, 
equine specific enzyme linked immunosorbent assay (ELISA) kit (Mercodia AB, Uppsala, 
Sweden), validated for use with equine plasma.30,31 The mean intra-assay coefficient of 
variation was 3.4% while the inter-assay coefficient of variation was 13%. The minimum 
detectable level of equine insulin was 0.01µg/l. Insulin concentrations during the clamp 
period were measured after dilution using commercially available human and bovine ELISA 
kits as appropriate (Mercodia AB, Uppsala, Sweden). The clamped insulin concentrations 
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were measured in a single assay at each age. For the human and bovine insulin assays, the 
minimum detectable of insulin was 0.04 µg/l and 0.02 µg/l while the intra-assay coefficient 
of variation was 3.4% and 3.8%, respectively.  
 
Tissue insulin receptor abundance 
Protein was extracted from liver and the four skeletal muscles and the protein concentration 
in the supernatant was determined using a bicinchoninic acid assay (BCA kit; Pierce, 
Rockford, IL). Western Blotting was performed as described previously32 using a primary 
antibody to the insulin receptor (InsR, subunit β (Insulin Rβ (C-19): (1:200; sc-711, Santa 
Cruz Biotechnology, inc, Delawere Avenue, Santa Cruz, CA, USA) and  to β-actin (1:10,000; 
sc-47778, Santa Cruz Biotechnology, inc, Delawere Avenue, Santa Cruz, CA, USA) to 
evaluate protein loading. Horseradish peroxidase-conjugated secondary antibodies to the host 
species were used as appropriate (1:5,000-1:10,000; ECLTM Anti-rabbit IgG and ECLTM 
Anti-mouse IgG; GE Healthcare Life Sciences, Little Chalfont, Bucks, UK). Protein 
abundance was detected using enhanced chemiluminescence reaction (ECL plus kit, 
Amersham Hiperfilm Bioscience, UK) and X-ray film (Fuji FPM100A processor) and 
analysed using the ImageJ program (ImageJ, Software, National Institute of Health, 
Bethesda, MD; http://rsb.info.nih.gov/ij). The depicted bands had the expected molecular 
weights.  
 
Calculations 
 
Glucose tolerance test: Relative insulin secretion (RIS) was calculated as area under the 
insulin curve (AUCI) divided by area under the glucose curve (AUCG). 
RIS =   AUCI (ng/l/min)  
 AUCG (mmol/l/min) 
 
Hyperinsulinsemic-euglycaemic clamp (HEC): As the glucose concentration is not 
maintained perfectly constant during the clamp, a space correction (SC) is made to account 
for the glucose that has been added or removed from the glucose space other than by 
metabolism.33 No correction was made for urinary losses of glucose, irrespective of whether 
the animals urinated or not during the course of the experiments. 
The SC (µmol/kg/min) was calculated from the equation: 
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 SC = (G2 - G1) x (0.19 btw) / (T x bwt)
33 
Where G2 and G1 are glucose concentration at the beginning and end of each interval of 
sampling, T is the time interval (10 minutes), btw is body weight in kg, and the term (0.19 x 
body weight) is the glucose space expressed in litres (l). The net steady state glucose infusion 
rate (Net GIR) (µmol/kg/min) was calculated by use of the following equation: 
Net steady state GIR  =  (GIR – SC)  
where GIR is the glucose infusion rate (µmol/kg/min) averaged over the clamp period and SC 
is the space correction.  Insulin sensitivity (µmol/min/kg/µg/l) was calculated as the net 
steady-state glucose infusion rate divided by the steady-state plasma insulin concentration 
during the clamp period.34  
IS      = Net steady-state glucose infusion rate (µmol/kg/min) 
 Steady-state plasma insulin concentration µg/l 
The steady-state plasma insulin concentration was calculated as the average of insulin 
concentrations during the clamp period. 
 
Statistical Analyses  
 
All results are expressed as means ± S.E.M. Plasma glucose and insulin concentrations during 
each experimental period were analysed using two-way analysis of variance (ANOVA) with 
repeated measures plus Tukey post hoc test, as appropriate. The area under the curve for 
glucose (AUCG) and insulin responses (AUCI) were calculated as the integrated plasma 
concentration after administration of glucose from 0 to 120 min above the baseline 
concentration at 0 min for all positive values. Statistical comparisons between groups were 
made using two ANOVA (treatment and time or treatment and sex) followed by Tukey post 
hoc test. Data were normalised by log transformation where required. The data for growth 
rate and from the HEC experiments at each age were analysed using two-way ANOVA using 
treatment and sex of the ponies as factors. Linear regression analyses were used to assess the 
relationships between birth weight, growth rate and AUCG and insulin sensitivity. Statistical 
analyses were performed using Sigma-Stat (Statistical Software version 2.0, San Jose, USA). 
For all statistical tests, significance was accepted at P<0.05.  
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RESULTS 
 
Biometry 
Birth weight did not differ between female and male foals (P>0.05, Table 1). There was also 
no difference in the body weight of the fillies and colts at 1 and 2 years of age (P>0.05, Table 
1). Neonatal treatment had no effect on body weight at either age (P>0.05, Table 1). In 
addition, there were no significant differences in the fractional growth rate with sex or 
neonatal treatment during the period of study (P>0.05, Table 1).  
 
Glucose tolerance  
At 1 and 2 years of age, there were no differences in the basal fasting concentrations of 
plasma glucose and insulin with neonatal treatment or sex of the animals (P>0.05, Table 1).  
At both ages, the increment in plasma glucose with respect to time and the maximal 
increment in plasma glucose were similar in males and females and did not differ with 
neonatal treatment (P>0.05, Table 1, Figure 1A). Similarly, the AUCG was unaffected by 
either sex or neonatal treatment of the animals, irrespective of their age (Figure 1B). The 
increment in plasma insulin with respect to time was also unaffected by neonatal treatment 
(P>0.05, Figure 1C).  However, the increment in plasma insulin from basal values was 
greater in females than males from 60 min to 120 min after glucose administration in the 
yearlings and from 30 min to120 min in the 2 year olds (P<0.02, Figure 1C). Similarly, the 
the maximum concentration of plasma insulin achieved during the 120 min period after 
glucose administration was significantly higher in females than males at both ages (P<0.04, 
Table 1). Consequently, the AUCI was significantly greater in females than males at both 
ages studied (P<0.02, Figure 1D). The relative insulin secretion were significantly greater in 
females than males at 2 but not 1 years of age (P<0.04, Table 1) and was unaffected by 
neonatal treatment at both ages (P>0.05, Table 1).  When the two sexes were analysed 
separately, there were no changes in the increments of glucose and insulin, the AUCG and 
AUCI or in RI between 1 and 2 years of age in either sex (P>0.05, two-way ANOVA, all 
cases) 
 
Insulin sensitivity  
Basal blood glucose concentrations did not vary with sex or neonatal treatment at either age 
(P>0.05, all cases; mean values: 1 year, 4.49 ± 0.17 mmol/l, n = 13; 2 years, 4.70 ± 0.19 
mmol/l, n = 17) and were clamped at these basal euglycaemic levels by 2-5h after beginning 
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the insulin infusion. At this time, insulin concentrations were supra-physiological and did not 
vary with neonatal treatment or sex of the animal at either 1 or 2 years of age (P>0.05, all 
cases: mean clamped values; 1 year, 52.5 ± 5.1 µg/l, n = 13, 2 years, 59.6 ± 5.6 µg/l, n =17). 
At both ages, the effectiveness of insulin in stimulating tissue glucose uptake was unaffected 
by neonatal treatment, whether measured as GIR or insulin sensitivity (P>0.05, Figure 2).  
Females had a greater GIR and insulin sensitivity than males as yearlings but not as 2 years 
olds (Figure 2). When the data from the two treatment groups were combined and analysed 
by two-way ANOVA with respect to age and sex of the animals, there was an interaction 
between these two factors in determining insulin sensitivity with a decline in insulin 
sensitivity with increasing age in females (P<0.001, n = 9) but not in males (P>0.05, n = 8). 
Insulin receptor abundance in the liver and selected skeletal muscles was unaffected by sex in 
a subset of the animals at 2 years of age (P>0.05, two-way ANOVA, all cases, Figure 3). 
However, skeletal muscle InsR abundance was influenced by neonatal treatment in a muscle 
specific manner with increased abundance in the soleus and gastrocnemius muscles and 
decreased abundance in the semitendinosus muscle of animals treated neonatally with ACTH 
compared to those receiving saline (Figure 3B-D). There was no apparent effect of neonatal 
treatment on InsR abundance in the liver or biceps muscle (Figure 3A&E).   
 
Relationships to birth weight and postnatal growth rates  
When all data were combined irrespective of sex or treatment at each of the two ages, there 
was no relationship between birthweight (BW) and either AUCG or insulin sensitivity in the 
yearlings (P>0.05, both cases). In contrast, at 2 years of age, AUCG was inversely related to 
the birthweight (Figure 4A, AUCG = 982 – 13.0BW, n = 18, r = -0.487, P = 0.04) while, 
conversely, insulin sensitivity was positively correlated to birth weight of the foals (Figure 
4B, IS = -159 + 15.6BW, n = 17, r = 0.658, P = 0.04). There were no relationships between 
the fractional growth rate until the age at study (g/kg/day) and either AUCG or insulin 
sensitivity at 1 and 2 years of age (P>0.05, all cases). Nor was there any relationship between 
birthweight and AUCI at 1 and 2 years of age when the data from the two sexes were 
analysed separately (P>0.05, all cases).  
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DISCUSSION 
 
The results demonstrate that sex, birth weight and neonatal glucocorticoid overexposure are 
all significant influences on the glucose-insulin dynamics of young adult horses. Insulin 
secretion in response to glucose was sex-linked at both ages studied as was insulin sensitivity 
in the yearlings.  Birth weight was related to the action of insulin in the 2 year olds, 
irrespective of whether insulin effectiveness was measured as area under the AUCG in the 
glucose tolerance test or more directly as insulin sensitivity using the hyperinsulinaemic-
euglycaemic clamp technique.  In contrast, neonatal glucocorticoid overexposure appeared to 
have little effect on glucose tolerance, insulin secretion or insulin sensitivity of the horses at 
either age studied, although it did affect InsR abundance of specific skeletal muscles at 2 
years in a manner independent of the sex of the animal. The current findings together with 
previous studies21-23 suggest that sex of the animal and environmental factors during fetal and 
early neonatal life are likely to be important in determining postnatal metabolic and 
endocrine phenotype in horses as occurs in other species.5,6,15,16  
 
Insulin secretion in response to glucose administration was greater in females than males at 
both 1 and 2 years, consistent with findings in newborn foals at 2 weeks of age.23 Sex-linked 
differences in glucose-stimulated insulin release have also been reported in rats, guinea pigs 
and sheep postnatally, particularly when there is a suboptimal environment during their 
intrauterine development.10,35-40 However, in these earlier studies, it was generally the males 
rather than the females that had a greater insulin response to exogenous glucose 
administration.  In part, this was due to sex-linked changes in pancreatic β cell mass and/or 
alterations in the intracellular pathways of insulin secretion.41-43 The mechanisms responsible 
for the differences in glucose-stimulated insulin secretion between the sexes in the horses in 
the current study are unknown. 
 
Despite the difference in insulin secretion between the male and female horses, glucose 
dynamics and AUCG were unaffected by the sex of the ponies at both ages studied. This 
suggests that insulin sensitivity was greater in males than females. However, direct 
measurement of insulin sensitivity using hyperinsulinaemic-euglycaemic clamps showed that 
the females were the more insulin sensitive sex as yearlings with no difference between the 
sexes at 2 years of age.  Sex-linked differences in adult insulin sensitivity have been observed 
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previously in rats, guinea pigs, sheep and humans and are often related to differences in 
adiposity.10,11,37,39,44,45 Body condition score was maintained at moderate in all animals in the 
current study so changes in adiposity are unlikely to account for the sex-linked differences in 
insulin sensitivity seen in the yearlings. In a subset of the current 2 year old horses, there 
were also no apparent sex-linked differences in InsR abundance in the liver or skeletal 
muscles, the main sites of insulin action.   Consequently, the paradoxical findings of no sex-
linked difference in AUCG but increased insulin secretion and sensitivity in the female 
yearlings relative to the males indicates that any increased insulin-stimulated glucose uptake 
during the glucose tolerance test is probably balanced by an equal and opposite decrease in 
insulin independent glucose disposal in the females. Conversely, in the older animals, there 
were no differences in insulin sensitivity or glucose tolerance between the sexes, despite the 
smaller insulin response to glucose administration in the males, which suggests insulin 
dependent glucose uptake may be less while insulin independent glucose disposal may be 
greater in males than females during glucose administration at 2 years of age. There may, 
therefore, be sexual dimorphism in the tissue expression and relative abundance of the 
various glucose transporters (GLUTs) in equine tissues, which differ with age. Certainly, in 
other species, there are sex-linked differences in tissue abundance of both the insulin 
sensitive GLUT isoform, GLUT4, and the insulin-insensitive isoforms, GLUT1 and GLUT2 
in the adult animal, particularly when it has experienced adverse conditions during 
intrauterine development.46-49  
 
In the current study, the weight specific rates of glucose infusion during the clamp were 
within the range of values reported previously for adult horses of several different breeds 
including ponies.33,50-54 Collectively, these studies suggest that insulin sensitivity may vary 
between breeds with a trend towards greater insulin resistance in ponies than more athletic 
breeds of horse.  They also indicate that insulin sensitivity may decline with age as GIR 
values tended to be lower in horses older than 12 years than in younger animals of the same 
breed.17,52,54 Certainly, in the current study, insulin sensitivity decreased between 1 and 2 
years of age in the females, although not the males. Since insulin sensitivity is affected by 
puberty in other species55, this may reflect, in part, the tendency for an earlier onset of 
puberty in fillies than colts.56 
 
The current finding that birth weight was inversely correlated to AUCG and positively related 
to insulin sensitivity in the 2 years old horses is consistent with previous studies of natural 
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and experimentally induced variations in birth weight in other species.5,6,15,16 Adult insulin 
sensitivity is known to be less in smaller than larger littermates in pigs and guinea pigs.10,57,58 
Similarly, in Standardbred horses, insulin sensitivity is less in pre-weaning foals that were 
growth restricted than in those growth enhanced by embryo transfer into smaller and larger 
breeds of mares, respectively.59 In addition, resistance to the effects of insulin is greater in 
adult rats of low birth weight, irrespective of whether intrauterine growth restriction was 
induced by uterine artery ligation, maternal glucocorticoid administration or restriction of 
dietary protein or calories intake.13,32,35,60  However, since insulin is an important regulator of 
fetal growth in species with relatively long gestational periods like the sheep and horse16, the 
relationship between adult insulin sensitivity and birth weight across the normal range may 
not be due to intrauterine programming but rather reflect an inherent, genetically determined 
insulin sensitivity tracking from fetal to early adult life. The absence of this relationship in 
the yearlings may again be the consequence of the changes in insulin sensitivity associated 
with puberty.55,56  
 
In the current study, neonatal glucocorticoid overexposure induced by ACTH treatment had 
little effect on adult insulin secretion or whole body insulin sensitivity of the young adult 
horses.  In contrast, this treatment reduced peak insulin concentrations in response to glucose 
administration in 2 and 12 week old foals and altered functioning of the hypothalamic-
pituitary-adrenal (HPA) axis in both the males and females as yearlings and 2 year olds.21,22  
At 2 years of age, neonatal glucocorticoid overexposure affected InsR expression in skeletal 
muscles differentially with increases, deceases and unaltered abundance depending on the 
specific muscle studied, which may reflect, in part, the differing fibre composition of the 
muscles.  While these changes in InsR abundance might alter insulin sensitivity of the 
individual muscles, they appeared to have no net effect on insulin-dependent glucose 
utilisation by the animal as a whole.  
 
In summary, insulin-glucose dynamics in the young adult horse varied with birth weight and 
sex in line with previous findings in newborn and older pre-weaning foals. This suggests that 
these metabolic characteristics are determined early in life and track into adulthood. 
However, whether this reflects the genotype of the individual or intrauterine programming of 
its metabolic phenotype remains unclear. In comparison, neonatal glucocorticoid 
overexposure appeared to have little effect on glucose-insulin dynamics of young adult horse 
as a whole, although insulin sensitivity of its individual skeletal muscles may have been 
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altered by the ACTH treatment. Taken together, the current and previous findings indicate 
that glucose metabolism of the young adult horse may be less sensitive to glucocorticoid 
programming during early neonatal life than functioning of its HPA axis.22 In other species, 
abnormalities in glucose metabolism and insulin sensitivity programmed in utero become 
more evident with increasing postnatal age and adiposity6,61 but whether this occurs in horses 
overexposed to glucocorticoids neonatally remains to be determined. Further studies are also 
required to identify the cellular and molecular basis of the differences in insulin-glucose 
dynamics linked to the sex and birth weight of the young adult horses. 
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FIGURE LEGENDS 
 
Figure 1:  Mean ± SEM values of the increment in plasma glucose (A), area under in the 
glucose curve (AUCG, B), the increment in plasma insulin (C) and the area under the insulin 
curve (AUCI, D) in response to administration of glucose (0.25g/kg) in female (dark symbols 
and columns) and male horses (white symbols and columns) at 1 year and 2 years of age after 
neonatal treatment with either ACTH (stippled columns, triangular symbols) or saline (Sal, 
filled columns, circular symbols). * significant effect of sex (two-way ANOVA, P<0.02). At 
1 year: Saline, females n = 6, males n = 4; ACTH, females n = 5, males n = 4. At 2 years: 
Saline females n = 5, males n=4; ACTH, females n = 5, males n =4. 
 
Figure 2: Mean ± SEM values of (A) the glucose infusion rate (GIR) and (B) insulin 
sensitivity during a hyperinsulinaemic-euglycaemic clamp in female (dark columns) and male 
horses (white columns) at 1 and 2 years of age after neonatal treatment with either ACTH 
(stippled columns) or saline (filled columns) * significant effect of sex (two-ANOVA, 
P<0.01).  At 1 year: Saline, females n = 2, males n =3; ACTH, females n = 4, males n = 4. At   
2 years: Saline, females n = 4, males n = 4; ACTH females n = 5, males n = 4.   
 
Figure 3: Relative abundance of the insulin receptor (InsR) to β-actin in individual female 
(F) and male (M) 2 year old horses after neonatal treatment with ACTH or saline and the 
mean value for the ACTH treated group (black columns) expressed relative to the mean for 
the saline controls (white columns) for (A) liver, (B) soleus muscle, (C) semitendinosus 
muscle, (D) gastrocnemius muscle and (E) biceps muscle.  * significantly different from 
value in saline treated group (P<0.03, two-way ANOVA).  
 
Figure 4: Relationship between birth weight (BW) and (A) the area under the glucose curve 
(AUCG) in response to glucose administration (0.25g/kg, AUCG = 982 – 13.0BW, n =18, r = 
-0.487, P = 0.04) and (B) insulin sensitivity (IS) measured using the hyperinsulinaemic-
euglycaemic clamp in horses at 2 years of age (IS = -159 + 15.6BW, n = 17, r = 0.658, P = 
0.0039).  
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Figure 3
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